NCT02099708View on ClinicalTrials.gov

Long-term Use of Takepron on the Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Non-steroidal Anti-inflammatory Drugs

CompletedOBSERVATIONAL
Enrollment

3,502

Participants

Timeline

Start Date

October 31, 2010

Primary Completion Date

March 31, 2014

Study Completion Date

March 31, 2014

Conditions
Gastric or Duodenal Ulcers
Interventions
DRUG

Lansoprazole

Lansoprazole Capsules 15 mg/ Orally Disintegrating (OD) Tablets 15 mg

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY